A Double-blind, Placebo-Controlled Study of Risperidone Addition in Serotonin Reuptake Inhibitor–Refractory Obsessive-compulsive Disorder

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Controlled Study ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718508456.793497749 ◽

2014 ◽

Author(s):

Eric Hollander

Keyword(s):

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Controlled Study ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

Double-Blind, Placebo-Controlled, Pilot Trial of Paliperidone Augmentation in Serotonin Reuptake Inhibitor–Resistant Obsessive-Compulsive Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.12m08278 ◽

2013 ◽

Vol 74 (06) ◽

pp. e527-e532 ◽

Cited By ~ 20

Author(s):

Eric A. Storch ◽

Andrew W. Goddard ◽

Jon E. Grant ◽

Alessandro S. De Nadai ◽

Wayne K. Goodman ◽

...

Keyword(s):

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Pilot Trial ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.715498009.791052959 ◽

2012 ◽

Author(s):

Evelyn Stewart ◽

Annie J Kuan

Keyword(s):

Serotonin Reuptake ◽

Controlled Study ◽

Treatment Resistant ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

Quetiapine augmentation to serotonin reuptake inhibitors for patients with obsessive compulsive disorder: a double-blind, placebo-controlled study

http://isrctn.org/> ◽

10.1186/isrctn40781401 ◽

2013 ◽

Author(s):

Nienke C C Vulink

Keyword(s):

Serotonin Reuptake ◽

Controlled Study ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

P.4.001 Adding quetiapine in serotonin reuptake inhibitor-resistant obsessive compulsive disorder: a randomised controlled study

European Neuropsychopharmacology ◽

10.1016/s0924-977x(05)81100-9 ◽

2005 ◽

Vol 15 ◽

pp. S527

Keyword(s):

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Controlled Study ◽

Obsessive Compulsive ◽

Compulsive Disorder ◽

Randomised Controlled Study ◽

Randomised Controlled

Faculty Opinions recommendation of Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718508460.793497753 ◽

2014 ◽

Author(s):

Eric Hollander

Keyword(s):

Serotonin Reuptake ◽

Controlled Study ◽

Treatment Resistant ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study

Journal of Psychopharmacology ◽

10.1177/0269881111431751 ◽

2012 ◽

Vol 26 (11) ◽

pp. 1456-1462 ◽

Cited By ~ 49

Author(s):

Antonio Bruno ◽

Umberto Micò ◽

Gianluca Pandolfo ◽

Domenico Mallamace ◽

Elisabetta Abenavoli ◽

...

Keyword(s):

Serotonin Reuptake ◽

Controlled Study ◽

Treatment Resistant ◽

Obsessive Compulsive ◽

Double Blind ◽

Double Blind Placebo ◽

Quetiapine augmentation of a serotonin reuptake inhibitor in treatment resistant obsessive-compulsive disorder: a multi-site, placebo-controlled study

http://isrctn.org/> ◽

10.1186/isrctn83050762 ◽

2012 ◽

Author(s):

Dan J Stein

Keyword(s):

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Controlled Study ◽

Treatment Resistant ◽

Obsessive Compulsive ◽

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

Current Psychopharmacologye ◽

10.2174/221155600303150629162749 ◽

2015 ◽

Vol 3 (3) ◽

pp. 219-225

Author(s):

Saeed Shoja Shafti

Keyword(s):

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Treatment Resistant ◽

Obsessive Compulsive ◽

Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor Treatment

Clinical Neuropharmacology ◽

10.1097/wnf.0000000000000456 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Michael Poyurovsky ◽

Abraham Weizman

Keyword(s):

Selective Serotonin Reuptake Inhibitor ◽

Reuptake Inhibitor ◽

Depressive Episode ◽

Serotonin Reuptake ◽

Selective Serotonin ◽

Obsessive Compulsive ◽

Compulsive Disorder ◽

Inhibitor Treatment